Trial Profile
Effects of rebamipide on nonsteroidal anti-inflammatory drugs [NSAID]-induced small bowel injury.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 08 Apr 2011
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- 01 Apr 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 30 Mar 2007 New trial record.